Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Revvity Revises 2024 Revenue Forecast To $2.76B-$2.82B From Prior Guidance Of $2.79B-$2.85B Versus Consensus Of $2.81B

Author: Benzinga Newsdesk | April 29, 2024 06:04am

Posted In: RVTY

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist